Top News
Phase 2 Results: Pembrolizumab Shows Antitumor Activity and a Manageable Safety Profile in Anal Squamous Cell Carcinoma
Primary Tumor Resection Prior to Chemotherapy Does Not Improve OS in Patients With Synchronous Metastatic CRC
Older Adults Are Less Likely to Receive Second-Line Therapy for Metastatic Colorectal Cancer, Study Reports
Sociodemographic Factors Influenced Survival in Young Adults With Colorectal Cancer
Study Reveals Differences Between the Genomic Profiles of Primary Tumors and Metastatic Lesions in Intrahepatic Cholangiocarcinoma
Tazverik Gets FDA Approval for Epithelioid Sarcoma
Prior Exposure to Antibiotics or Antacids Did Not Reduce Immunotherapy Response in Advanced HCC
Addition of PEGPH20 to Frontline Chemotherapy Did Not Improve Clinical Outcomes in Pancreatic Cancer Subgroup
Addition of Pegilodecakin to FOLFOX Did Not Improve OS in Metastatic Pancreatic Cancer
EDITORIAL ADVISORY BOARD
E. David Crawford, MD
Jeffrey M. Farma, MD
Featured
-
2020 Gastrointestinal Cancers Symposium Coverage
News coverage from the 2020 Gastrointestinal Cancers Symposium in San Francisco, CA. -
Tivozanib Shows Superior Safety Profile Across TKIs in Metastatic Renal Cell Carcinoma
For the study, researchers conducted a literature review and network meta-analysis of phase 2/3 randomized controlled trials of approved first-line TKI therapies for mRCC. -
Open Radical Nephrectomy for RCC May Increase Circulating Tumor Cells
The investigators observed significantly higher postoperative CTC counts in the open radical nephrectomy group compared with the other 3 groups in the study. -
Cosmetics or Personal Care Products and Cancer
This fact sheet reviews studies that evaluated a potential link between hair dye, deodorant/antiperspirant, or personal care product use and cancer. -
Researchers Propose Adding Sequencing Data to TNM Staging in Non-Small Cell Lung Cancer
Experts acknowledged the growing importance of genomics to the field, but said more research is needed to justify changing current practices. -
The FDA Approval Process Needs Refinement, Not a Total Overhaul
Even though overall drug development times have not changed, questions about the clinical benefit of the drugs that have been approved through expedited pathways are being raised. -
How Durable Are Responses to Targeted Therapies Across Single-Arm Cancer Trials?
Drugs approved based on changes to surrogate biomarker levels may be subject to measurement bias, according to investigators.
More Features
The Benefits of Yoga for Cancer Patients
A review of the ways that a yoga practice can help patients cope with their cancer and manage the physical symptoms and side effects of treatment.
CAR-T Therapy: Supporting Evidence and Value Considerations
Although CAR-T therapies have shown favorable response rates, they can be incredibly costly and may not be priced in alignment with their benefits.
Emerging Clinical Tool Predicts Risk of Persistent Use of Opioids After Treatment in Patients With Cancer
Investigators at UCSD sought to create a tool to help clinicians predict patients’ risk of persistent opioid use after treatment.
Kegel Exercises After Prostate Surgery Called Into Question
Pelvic physical therapy may be more appropriate than Kegel exercises in managing post-radical prostatectomy pain and stress urinary incontinence, according to a new study.
MRI-Guided Transurethral Ultrasound Ablation: Promising Data in Prostate Cancer
MRI-guided TULSA uses a transurethral catheter to precisely apply ultrasound and MRI-guided thermotherapy to ablate cancerous tissue within the prostate gland.
